Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Community program to support patients with heart and lung conditions after hospital discharge

Official title: Reforça't: A Randomized Community Clinical Trial With a Social and Healthcare Approach to Improve Functional Outcomes in Patients With Chronic Cardiac, Respiratory, or Mixed Conditions After Hospital Discharge

Run by Corporació de Salut del Maresme i la Selva · NCT06897410 · Data updated 2026-11-12

This study is testing a community program called Reforça't to see if it helps older patients with heart and lung conditions stay healthy and avoid going back to the hospital after they leave.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment200 (estimated)
SponsorCorporació de Salut del Maresme i la Selva
Academic / other
Locations1 site (Calella, Barcelona)
StatusRecruiting
StartedJanuary 13, 2025
Main results expectedJune 30, 2026
Study endsJune 30, 2026
Registry record updatedMay 30, 2025
Trial IDNCT06897410 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 65 or older who have been hospitalized for cardiac or respiratory issues and reside within the health coverage area of the participating hospital.

Probably not a fit

Patients who are institutionalized in nursing homes or those already enrolled in home care programs may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of the Reforça't program, an interdisciplinary, community-based intervention designed for patients aged 65 and older with chronic cardiorespiratory conditions. The program seeks to reduce 30-day hospital readmissions and improve functional outcomes by providing comprehensive care following hospital discharge. Participants will be randomly assigned to either the Reforça't program or standard care, with assessments conducted before and after the intervention to measure health outcomes, medication adherence, and quality of life. The study will compare the two groups to determine the program's impact on readmission rates and overall patient well-being.

Why it matters

Potential benefit: If successful, this program could significantly reduce hospital readmissions and enhance the quality of life for elderly patients with chronic heart and lung conditions.

How similar studies have gone: Other studies have shown promise with community-based interventions for similar patient populations, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Users admitted to the Polivalent Observation Units, Internal Medicine, or Hospital at home.
* Individuals aged 65 years or older.
* Hospital admission due to decompensation of a cardiac, respiratory, or mixed condition.
* Place of residence within the health coverage area of Sant Jaume de Calella Hospital - Corporació de Salut del Maresme i la Selva.
* Willingness to participate in the study as gathered by the signing of an informed consent document

Exclusion Criteria:

* Users institutionalized in a nursing home
* Users already enrolled in home care programs
* Users in the Advanced Chronic Care Model program with a limited life prognosis
* Users on the waiting list for organ transplantation
* Users with language barriers
* Users with a GDS (Global Deterioration Scale) score of 5 or higher
* Users who have already been included in the Reforça't program

Where it's running

  • Hospital Comarcal de Calella - Corporació de Salut del Maresme i la Selva
    Calella, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.